Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Pharma-Bio Serv (PBSV) over the last 13 years, with Q4 2025 value amounting to $406680.0.

  • Pharma-Bio Serv's Non-cash Items rose 2576.31% to $406680.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $406680.0, marking a year-over-year increase of 2576.31%. This contributed to the annual value of $406680.0 for FY2025, which is 476226.69% up from last year.
  • Pharma-Bio Serv's Non-cash Items amounted to $406680.0 in Q4 2025, which was up 2576.31% from $323370.0 recorded in Q4 2024.
  • Pharma-Bio Serv's Non-cash Items' 5-year high stood at $406680.0 during Q4 2025, with a 5-year trough of $263330.0 in Q4 2023.
  • Over the past 5 years, Pharma-Bio Serv's median Non-cash Items value was $396700.0 (recorded in 2021), while the average stood at $358016.0.
  • In the last 5 years, Pharma-Bio Serv's Non-cash Items plummeted by 3416.75% in 2023 and then soared by 2576.31% in 2025.
  • Pharma-Bio Serv's Non-cash Items (Quarter) stood at $396700.0 in 2021, then grew by 0.83% to $400000.0 in 2022, then tumbled by 34.17% to $263330.0 in 2023, then increased by 22.8% to $323370.0 in 2024, then rose by 25.76% to $406680.0 in 2025.
  • Its Non-cash Items stands at $406680.0 for Q4 2025, versus $323370.0 for Q4 2024 and $263330.0 for Q4 2023.